These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14718801)

  • 1. Treatment and care of neurotoxicity from taxane anticancer agents.
    Makino H
    Breast Cancer; 2004; 11(1):100-4. PubMed ID: 14718801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expert consensus on standardized management of taxane-related peripheral neuropathy].
    Taxane-related Peripheral Neuropathy Standardized Management Group
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):170-179. PubMed ID: 32252195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques for the neurological examination of taxane-induced neuropathy.
    Ohsumi S; Sunada Y
    Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxane induced neuropathy in patients affected by breast cancer: Literature review.
    De Iuliis F; Taglieri L; Salerno G; Lanza R; Scarpa S
    Crit Rev Oncol Hematol; 2015 Oct; 96(1):34-45. PubMed ID: 26004917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotoxicity of taxanes: symptoms and quality of life assessment.
    Kuroi K; Shimozuma K
    Breast Cancer; 2004; 11(1):92-9. PubMed ID: 14718800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of taxane neurotoxicity.
    Hagiwara H; Sunada Y
    Breast Cancer; 2004; 11(1):82-5. PubMed ID: 14718798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current methods for the assessment and management of taxane-related neuropathy.
    Smith EM
    Clin J Oncol Nurs; 2013 Feb; 17 Suppl():22-34. PubMed ID: 23360700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life considerations with taxane-based therapy in metastatic breast cancer.
    Maxwell C
    Clin J Oncol Nurs; 2013 Feb; 17 Suppl():35-40. PubMed ID: 23360701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes.
    Blum JL; Savin MA; Edelman G; Pippen JE; Robert NJ; Geister BV; Kirby RL; Clawson A; O'Shaughnessy JA
    Clin Breast Cancer; 2007 Dec; 7(11):850-6. PubMed ID: 18269774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
    Rizzo R; Spaggiari F; Indelli M; Lelli G; Baricordi OR; Rimessi P; Ferlini A
    Breast Cancer Res Treat; 2010 Nov; 124(2):593-8. PubMed ID: 20632082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer.
    Sands S; Ladas EJ; Kelly KM; Weiner M; Lin M; Ndao DH; Dave A; Vahdat LT; Bender JG
    Support Care Cancer; 2017 Mar; 25(3):701-708. PubMed ID: 27830395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy.
    Blum JL; Dees EC; Vukelja SJ; Amare M; Gill DP; McMahon RT; Ilegbodu D; Asmar L; O'Shaughnessy JA
    Clin Breast Cancer; 2007 Feb; 7(6):465-70. PubMed ID: 17386123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.
    Wampler MA; Hamolsky D; Hamel K; Melisko M; Topp KS
    Clin J Oncol Nurs; 2005 Apr; 9(2):189-93. PubMed ID: 15853162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxanes in elderly breast cancer patients.
    Wildiers H; Paridaens R
    Cancer Treat Rev; 2004 Jun; 30(4):333-42. PubMed ID: 15145508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of taxanes in the treatment of breast cancer.
    Capri G; Tarenzi E; Fulfaro F; Gianni L
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in taxane therapy for metastatic breast cancer.
    ONS News; 2004; 19(9 Suppl):75-6. PubMed ID: 15478598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paclitaxel in metastatic breast cancer: a trial of two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines.
    Gianni L; Munzone E; Capri G; Villani F; Spreafico C; Tarenzi E; Fulfaro F; Caraceni A; Martini C; Laffranchi A
    J Natl Cancer Inst; 1995 Aug; 87(15):1169-75. PubMed ID: 7674322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taxane-induced nail changes: Predictors and efficacy of the use of frozen gloves and socks in the prevention of nail toxicity.
    Can G; Aydiner A; Cavdar I
    Eur J Oncol Nurs; 2012 Jul; 16(3):270-5. PubMed ID: 21784705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.